Abstract
Amiodarone-induced SIADH is a rare but serious side effect of this drug. We report two cases of mild hyponatremia, observed in the last five years, and discuss the role played by age, sex and dose of amiodarone as well as the influence that this molecule may have on aquaporin-2 water channel expression in the renal collecting ducts.
Keywords: Amiodarone, aquaporin-2, hyponatremia, hypothyroidism, renal collecting ducts, SIADH.
Endocrine, Metabolic & Immune Disorders - Drug Targets
Title:Amiodarone-Induced SIADH: Two Cases Report
Volume: 14 Issue: 2
Author(s): Michele Iovino, Nicola Iovine, Antonio Petrosino, Brunella Licchelli, Vito A. Giagulli, Massimo Iacoviello, Edoardo Guastamacchia and Vincenzo Triggiani
Affiliation:
Keywords: Amiodarone, aquaporin-2, hyponatremia, hypothyroidism, renal collecting ducts, SIADH.
Abstract: Amiodarone-induced SIADH is a rare but serious side effect of this drug. We report two cases of mild hyponatremia, observed in the last five years, and discuss the role played by age, sex and dose of amiodarone as well as the influence that this molecule may have on aquaporin-2 water channel expression in the renal collecting ducts.
Export Options
About this article
Cite this article as:
Iovino Michele, Iovine Nicola, Petrosino Antonio, Licchelli Brunella, Giagulli A. Vito, Iacoviello Massimo, Guastamacchia Edoardo and Triggiani Vincenzo, Amiodarone-Induced SIADH: Two Cases Report, Endocrine, Metabolic & Immune Disorders - Drug Targets 2014; 14(2) . https://dx.doi.org/10.2174/1871530314666140407111410
DOI https://dx.doi.org/10.2174/1871530314666140407111410 |
Print ISSN 1871-5303 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-3873 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
The Endocrine Function of Adipose Tissue
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Editorial [Hot Topic:Applications of Angiotensin Converting Enzyme Inhibitors and of Angiotensin II Receptor Blockers in Pharmacology and Therapy: An Update (Executive Editor: Agostino Molteni)]
Current Pharmaceutical Design Structure, Function and Biological Relevance of Prolyl Oligopeptidase
Current Protein & Peptide Science Monitoring Calcific Aortic Valve Disease: The Role of Biomarkers
Current Medicinal Chemistry Dermatologic Manifestations in the Antiphospholipid Syndrome
Current Rheumatology Reviews Biomarkers of Aging with Prognostic and Predictive Value in Non-Oncological Diseases
Current Medicinal Chemistry Role of NADPH Oxidase in Hypertension and Diabetic Nephropathy
Current Hypertension Reviews Novel Oral Anticoagulants for Venous Thromboembolism with Special Emphasis on Risk of Hemorrhagic Complications and Reversal Agents
Current Drug Therapy Gender Related Issues in the Management of Heart Failure
Current Pharmaceutical Design Molecular Pathophysiology of Renal Tubular Acidosis
Current Genomics Current and Future Drug Treatments for Glioblastomas
Current Medicinal Chemistry Liver and Pancreatic Disease in Cystic Fibrosis: Clinics and Drug Therapy
Clinical Immunology, Endocrine & Metabolic Drugs (Discontinued) The Vasculature as a Target in the Treatment of Pulmonary Emphysema
Current Drug Targets New Trends in Thromboxane and Prostacyclin Modulators
Current Medicinal Chemistry Haptoglobin Polymorphism and Lacunar Stroke
Current Neurovascular Research Autoimmune Diseases and Atherosclerosis: The Inflammatory Connection
Current Immunology Reviews (Discontinued) Actinomycetes as a Paramount Source of Biologically Important Enzyme Inhibitors – “A Boon to Mankind”
Current Bioactive Compounds Metabolic Syndrome Racial Differences in Adolescents
Current Diabetes Reviews Vascular Calcifications in Chronic Kidney Disease: Are There New Treatments?
Current Vascular Pharmacology Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?
Current Pharmaceutical Design